Parra OI, Estrada GRA, Ruiz AGJ

Language: Spanish
References: 21
Page: 20-23
PDF size: 104.65 Kb.

ABSTRACT

Background: Sticky platelet syndrome (SPS), described in 1983, is a clinical entity that supposes a disorder in platelet aggregation characterized by its abnormal increase in numbers and a trend towards the occurrence of arterial and venous vasoocclusive phenomena,. Its pathogenesis remains unknown; its existence can only be determined by platelet aggregation tests. The prevalence of the SPS is unknown, but there are data that suggest that it is frequent. Some authors have indicated that SPS is the cause of 20 % of the inexplicable arterial thrombosis and 13 % of venous thrombosis where it is not possible to identify the cause.
Objectives: To review available information about sticky platelet syndrome and its importance in Mexico.
Conclusions: SPS is the most frequent thrombophilic condition in Mexico; there are few reports of the detailed evaluation of Mexican patients, which makes it imperative to conduct rigorous clinical and laboratory studies to document the importance of this syndrome.

REFERENCES

1. Mammen EF. Sticky platelet syndrome. Semin Thromb Hemost. 1999;25:361-5.

2. Holliday PL, Mammen EF, Gilroy J, Buday J, et al. Sticky platelet syndrome and cerebral infarction in young adults. Ninth International Joint Conference on Stroke and Cerebral Circulation 1983; Phoenix, AZ. Abstracts.

3. Chittoor SR, Elsehety AE, Roberts GF, Laughlin WR. Sticky platelet syndrome: a case report and review of the literature. Clin Appl Thromb Hemost 1998;4:280-4.

4. Ruiz-Argüelles GJ, Ruiz DGJ, López MB. El “síndrome de las plaquetas pegajosas”, una causa frecuente pero ignorada de trombofilia. Rev Invest Clin 2002;54:394-96.

5. Rubenfire M, Blevins RD, Barnhart M, Housholder S, Selik N, Mammen EF. Platelet hyperaggregability in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol. 1986;57:657-60.

6. Mammen EF. Ten years experience with the sticky platelet syndrome. Clin Appl Thromb Hemost 1995;1:66-72.

7. Bick RL. Sticky platelet syndrome: a common cause of unexplained venous and arterial thrombosis. Results of prevalence and treatment outcome. Clin Appl Thromb Hemost 1998;4:77-81.

8. Hernández HD, Villa R, Murillo BLM, y col. Hiperagregabilidad plaquetaria y síndrome de plaquetas pegajosas (SPP) en eventos vasculares cerebrales en jóvenes. Rev Hematol 2002;3:19.

9. Ruiz-Arguelles GJ, Gonzalez-Estrada S, Garces-Eisele J, Ruiz-Arguelles A. Primary thrombophilia in Mexico: a prospective study. Am J Hematol. 1999;60:1-5.

10. Ruiz-Arguelles GJ, Garces-Eisele J, Reyes-Nuñez V, Ramirez- Cisneros F. Primary thrombophilia in Mexico II: factor V G1691A (Leiden), prothrombin G20210A and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos. Am J Hematol. 2001;66:28-31.

11. Ruiz-Arguelles GJ, Lopez-Martinez B, Cruz-Cruz D, Esparza- Silva L, et al. Primary thrombophilia in Mexico III. A prospective study of the sticky platelet syndrome. Clin Appl Thromb Hemost. 2002;8:273-7.

12. Ruiz-Argüelles GJ, Poblete-Naredo I, Reyes-Nuñez V, Garces- Eisele J, et al. Primary thrombophilia in Mexico IV: frequency of the Leiden, Cambridge, Hong Kong, Liverpool and HR2 haplotype polymorphisms in the factor V gene of a group of thrombophilic in Mexican Mestizo patients. Rev Invest Clin 2004;56:600-4.

13. Ruiz-Argüelles GJ, Valdés-Tapia P, Ruiz-Delgado GJ. El concepto de trombofilia multifactorial: el caso de México. Rev Hematol 2005;6:35-42.

14. Ruiz-Argüelles GJ, Lopez-Martinez B, Valdes-Tapia P, Gomez- Rangel JD, et al. Primary thrombophilia in Mexico V. A comprehensive prospective study indicates that most cases are multifactorial. Am J Hematol 2005;78:21-6.

15. Parra-Ortega I, Ruiz-Argüelles GJ. Trombofilia multifactorial en México: descripción de 18 pacientes mestizos mexicanos con el síndrome de las plaquetas pegajosas. Med Inter Mex 2006;22:93-6.

16. Born GV, Cross MJ. The aggregation of blood platelets. J Physiol 1963;168:178-95.

17. Zoller B, Dahlback B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994;343:1536-8.

18. Lunghi B, Castoldi E, Mingozzi F, Bernardi F. A new factor V gene polymorphism (His 1254 Arg) present in subjects of african origin mimics the R2 polymorphism (His 1299 Arg). Blood 1998;91:364-5.

19. Kluijtmans LA, Van den Heuvel LP, Boers GH, Frosst P, et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996;58:35-41.

20. Schafer AI, Levine MN, Konkle BA, Kearon C. Thrombotic disorders: diagnosis and treatment. Hematol Am Soc Hematol Educ Program 2003:520-39.

21. Ruiz-Argüelles GJ, González Carrillo ML, Estrada Gómez RA, Valdés Tapia P, et al. Trombofilia primaria en México. Parte VI: falta de asociación estadística entre las condiciones trombofílicas heredadas. Gac Med Mex 2007 (en prensa).